Lukas Gaksch | MD
banner
lukas-gaksch.bsky.social
Lukas Gaksch | MD
@lukas-gaksch.bsky.social
Hematologist and physician scientist
Focused on CAR-T cell therapy, stem cell transplantation, and GvHD
Based at the Medical University of Graz
Pinned
Hematologist and physician scientist based @medunigraz.at (Austria), working on cellular therapies – especially CAR-T and stem cell transplantation.

Currently focusing on GvHD and immune complications in hematologic malignancies.

Happy to connect with colleagues and researchers on here.
Honored to be featured in the “NEXT GENERATION” interview series by krebs:hilfe!

Shared thoughts on medical education & how young hematologists can help shape the future of cellular therapies.

Interview (DE): www.medmedia.at/krebs-hilfe/...

#Hematology #CAR_T #CellularTherapy #PhysicianScientist
krebshilfe.net
September 29, 2025 at 4:05 PM
Glad to have contributed to our lab’s new publication on chemokine receptors in follicular lymphoma.
Congrats to Antonella Zupo, Katrin Pansy & Alexander Deutsch — and thanks to the whole team for the great work on this project.
👉 doi.org/10.1002/jha2...

#Hematology #Lymphoma
@medunigraz.at
Chemokine Receptor Profiles as Predictors of Survival and Early Progression in Follicular Lymphoma
Objective: Classical follicular lymphoma (FL) is a heterogeneous malignancy. Early progression within 24 months (POD24) is linked to poor outcomes. However, precise risk stratification remains unclea...
doi.org
August 31, 2025 at 9:52 AM
New article in SPECTRUM ONKOLOGIE with Prof. Neumeister:
Autologous stem cell boosts after CD19 CAR T therapy and delayed hematopoietic recovery.

Link (German): www.medmedia.at/spectrum-onk...

#CAR_T #StemCellBoost #CellularTherapy #Hematology

Image: Hypocellular marrow post-CAR-T
July 13, 2025 at 8:29 PM
Hematologist and physician scientist based @medunigraz.at (Austria), working on cellular therapies – especially CAR-T and stem cell transplantation.

Currently focusing on GvHD and immune complications in hematologic malignancies.

Happy to connect with colleagues and researchers on here.
July 13, 2025 at 6:10 PM